Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of Health Canada Patents covering Tox21_300583.

Client Email

Product

Tox21_300583
HEALTH CANADA PATENTS

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Tox21_300583

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

15 API Suppliers, 14 USDMF, 1 CEP/COS, 2 EU WC, 4 NDC API, 1 Listed Suppliers

15 API Suppliers
14 USDMF
1 CEP/COS
2 EU WC
4 NDC API
1 Listed Suppliers

FINISHED DOSAGE FORMULATIONS

99 FDF Dossiers, 47 FDA Orange Book, 18 Europe, 21 South Africa, 13 Listed Dossiers

99 FDF Dossiers
47 FDA Orange Book
18 Europe
21 South Africa
13 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FOR SOLUTION;ORAL - 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE;ORAL - 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
FOR SOLUTION;ORAL - 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc, 13 SPI Pharma, 9 DKSH, 7 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 2 Actylis, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 9 BASF, 4 DFE Pharma, 1 Finar, 4 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 12 Kerry, 1 Kima Chemical, 3 Lonza Capsugel, 13 Microlex e.U, 2 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 1 Qualicaps, 15 Roquette, 1 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 1 The Dow Chemical Company, 1 Valens Pharmachem, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

47 Fillers, Diluents & Binders, 27 Direct Compression, 24 Thickeners and Stabilizers, 16 Taste Masking, 15 Disintegrants & Superdisintegrants, 15 Granulation, 14 Coating Systems & Additives, 13 Co-Processed Excipients, 13 Lubricants & Glidants, 11 Chewable & Orodispersible Aids, 8 Empty Capsules, 6 Film Formers & Plasticizers, 6 Controlled & Modified Release, 6 Parenteral, 5 Solubilizers, 4 Topical, 4 Rheology Modifiers, 3 Coloring Agents, 2 Emulsifying Agents, 1 API Stability Enhancers, 1 Surfactant & Foaming Agents

47 Fillers, Diluents & Binders
27 Direct Compression
24 Thickeners and Stabilizers
16 Taste Masking
15 Disintegrants & Superdisintegrants
15 Granulation
14 Coating Systems & Additives
13 Co-Processed Excipients
13 Lubricants & Glidants
11 Chewable & Orodispersible Aids
8 Empty Capsules
6 Film Formers & Plasticizers
6 Controlled & Modified Release
6 Parenteral
5 Solubilizers
4 Topical
4 Rheology Modifiers
3 Coloring Agents
2 Emulsifying Agents
1 API Stability Enhancers
1 Surfactant & Foaming Agents

DIGITAL CONTENT

3 NEWS #PharmaBuzz

3 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

9 Finished Drug Prices

9 Finished Drug Prices

MARKET PLACE

1 APIs

1 APIs

PATENTS & EXCLUSIVITIES

9 Health Canada Patents

9 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 2 USP, 2 Others

3 EDQM
2 USP
2 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

9 All

01 9Blank

filter Patent Reset all filters

9 All

01 91293447

filter Product Reset all filters

9 All

01 9Blank

filter Dosage Reset all filters

9 All

01 9Blank

filter Exp Date Reset all filters

9 All

01 92008-12-24

Product Main Page

01

Stavudine

Formnext Forum

Not Confirmed

Country

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2008-12-24

Date Granted :

Brand Name :

Patent Number : 1293447

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2008-12-24

Date Granted :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Stavudine

Formnext Forum

Not Confirmed

Country

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2008-12-24

Date Granted :

Brand Name :

Patent Number : 1293447

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2008-12-24

Date Granted :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Stavudine

Formnext Forum

Not Confirmed

Country

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2008-12-24

Date Granted :

Brand Name :

Patent Number : 1293447

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2008-12-24

Date Granted :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

Stavudine

Formnext Forum

Not Confirmed

Country

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2008-12-24

Date Granted :

Brand Name :

Patent Number : 1293447

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2008-12-24

Date Granted :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

Stavudine

Formnext Forum

Not Confirmed

Country

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2008-12-24

Date Granted :

Brand Name :

Patent Number : 1293447

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2008-12-24

Date Granted :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

Stavudine

Formnext Forum

Not Confirmed

Country

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2008-12-24

Date Granted :

Brand Name :

Patent Number : 1293447

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2008-12-24

Date Granted :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

07

Stavudine

Formnext Forum

Not Confirmed

Country

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2008-12-24

Date Granted :

Brand Name :

Patent Number : 1293447

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2008-12-24

Date Granted :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

08

Stavudine

Formnext Forum

Not Confirmed

Country

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2008-12-24

Date Granted :

Brand Name :

Patent Number : 1293447

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2008-12-24

Date Granted :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

09

Stavudine

Formnext Forum

Not Confirmed

Country

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2008-12-24

Date Granted :

Brand Name :

Patent Number : 1293447

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2008-12-24

Date Granted :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?